Company intelligence / Profile preview

GenIbet Biopharmaceuticals

Oeiras, Lisbon, Portugalgenibet.com ↗
Ownership
Private
Employees
~60
Development stage
Other
01

Overview

CDMO specializing in GMP manufacturing for preclinical and Phase I/II clinical trials of biologics and novel modalities.

Modalities
Recombinant proteinVaccineRNA therapyLive biotherapeutic product therapyCell therapyGene therapyOncolytic virus therapy
Industry
Contract Manufacturing Organization
02

Partnerships

ModernaSeres Therapeutics

Beyond the preview

Go deeper on GenIbet Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenIbet Biopharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call